BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SIM0505 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SIM0505\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06792552-2730@assetmemo.bio
DTSTAMP:20261121T004458Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:SIM0505: Phase 1 readout est. (NCT06792552)
DESCRIPTION:SIM0505\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase
  I Study of SIM0505 in Participants With Advanced Solid Tumors\nEstimated 
 primary completion: February 2028. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/sim0505#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT06792552
URL:https://assetmemo.bio/drug/sim0505#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
